To include your compound in the COVID-19 Resource Center, submit it here.

Myrexis cancer news

Myrexis retained Stifel Nicolaus Weisel to evaluate strategic alternatives. Myrexis also suspended development of

Read the full 149 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE